Objective-To examine the use of thrombolytic treatment in acute myocardial infarction when faced with perceived contraindications to treatment and to explore the justification for withholding treatment in such clinical situations. Methods-Interview survey of all doctors responsible administering thrombolysis to patients with acute myocardial infarction at a teaching hospital in the UK from March to May 1997. Results-20 doctors were interviewed and asked whether they would give or withhold thrombolysis in a series of 19 clinical situations. These included patients presenting with both an acute myocardial infarction and one of the following associated conditions: a confirmed gastrointestinal haemorrhage, a suspected gastrointestinal haemorrhage, a peptic ulcer, an abdominal aortic aneurysm, a recent cerebrovascular accident, a known intracranial aneurysm, a known intracranial tumour, a recent dental extraction, recent surgery, severe hypertension, proliferative diabetic retinopathy, a history of bleeding diathesis, coma, recent cardiopulmonary resuscitation, pregnancy, menstruation, and a recent central venous puncture. In all but one of the clinical situations (definite current gastrointestinal haemorrhage) there was wide variation in response as to what constitutes a contraindication to thrombolytic treatment. Overall, a substantial proportion of doctors (35%-95%) would withhold treatment on account of any one of these clinical histories.
Perceived contraindications to thrombolytic treatment in acute myocardial infarction. A survey at a teaching hospital David S Wald Abstract Objective-To examine the use of thrombolytic treatment in acute myocardial infarction when faced with perceived contraindications to treatment and to explore the justification for withholding treatment in such clinical situations. Methods-Interview survey of all doctors responsible administering thrombolysis to patients with acute myocardial infarction at a teaching hospital in the UK from March to May 1997. Results-20 doctors were interviewed and asked whether they would give or withhold thrombolysis in a series of 19 clinical situations. These included patients presenting with both an acute myocardial infarction and one of the following associated conditions: a confirmed gastrointestinal haemorrhage, a suspected gastrointestinal haemorrhage, a peptic ulcer, an abdominal aortic aneurysm, a recent cerebrovascular accident, a known intracranial aneurysm, a known intracranial tumour, a recent dental extraction, recent surgery, severe hypertension, proliferative diabetic retinopathy, a history of bleeding diathesis, coma, recent cardiopulmonary resuscitation, pregnancy, menstruation, and a recent central venous puncture. 4 There is considerable variation in practice between doctors and hospitals in the use of thrombolysis in the management of acute myocardial infarction.5 6 While most doctors are likely to withhold thrombolytic treatment in certain situations, such as a patient presenting with an acute myocardial infarction and a gastrointestinal haemorrhage, the decision to withhold thrombolysis in some cases is perceived as difficult. There is also a tendency for clinicians to adopt a more conservative approach for fear of causing harm. Such action may limit the use of an effective treatment for a condition with a high mortality. It has already been reported that the presence of an abdominal aortic aneurysm is perceived by many doctors as a reason to forego thrombolysis in acute myocardial infarction.7 To examine this issue with respect to other perceived contraindications a survey was conducted at a teaching hospital in the UK, and the results on abdominal aortic aneurysm are included for completeness.
Methods
All doctors responsible for the early management of acute myocardial infarction were interviewed as to whether they would give or withhold thrombolysis in a series of clinical situations. These included patients presenting with both an acute myocardial infarction and one of the following associated conditions: a confirmed gastrointestinal haemorrhage, a suspected gastrointestinal haemorrhage, a peptic ulcer, an abdominal aortic aneurysm, a recent stroke, a known intracranial aneurysm, a known intracranial tumour, a recent dental extraction, recent surgery, severe hypertension, proliferative diabetic retinopathy, a history of bleeding diathesis, coma, recent cardiopulmonary resuscitation, pregnancy, menstruation, and a recent central venous puncture. Twenty 
Conclusion
The decision to institute thrombolysis in acute myocardial infarction is today left largely to junior medical senior house officers and registrars whose practice varies widely. Perceived contraindications to thrombolysis are often based on intuitive fears of causing harm rather than evidence. In order to realise the benefits of thrombolytic treatment in acute myocardial infarction, clinicians should be encouraged to give rather than withhold thrombolysis in circumstances where the risks, although unknown, are likely to be small and far outweighed by the benefit of treatment.
EMERGENCY CASEBOOK
Waldenstrom macroglobulinaemia presenting as bleeding diathesis with paradoxical coagulation ofblood samples A 79 year old man, who had been well all his life, presented to our accident and emergency department with episodic epistaxis and bleeding gums of two days' duration. On examination there were splinter haemorrhages in every finger. Petechiae were present in the hands and over the shins. Cardiac murmurs consistent with aortic sclerosis and mitral regurgitation were present. The patient was apyrexial. Blood taken by different doctors on three occasions, collected in EDTA and citrate, consistently clotted on reaching the laboratory. On the fourth occasion, blood taken and maintained at body temperature allowed analysis. The following results were obtained: haemoglobin 98 g/l, mean corpuscular volume 99 fl, white cell count 5.7 x 109/I, platelet count 127 x I0/l, erythrocyte sedimentation rate 120 mm/hour, prothrombin time 23 seconds, activated partial thromboplastin time 49 seconds, thrombin time 10 seconds, globulin 56 g/l, albumin 36 g/l, and bilirubin 29 jimol/l. A provisional diagnosis was made of a lymphoproliferative disorder with possible cold agglutinins. This was confirmed the next day on bone marrow examination as Waldenstrom's macroglobulinaemia. The bone marrow showed a diffuse increase in lymphoplasmacytoid cells. Immunophenotyping confirmed a monoclonal proliferation of IgM (K) cells with a paraprotein concentration of 37 g/l. Abdominal ultrasound confirmed a normal sized liver and spleen. The patient was started on chlorambucil and remains well on regular follow up. (fig 1) . This process only occurs at temperatures below 37°C and can be reversed by warming the blood. Although the phenomena of cryoglobins causing cold agglutination of blood at temperatures below 37°C is well documented, an extensive search of literature has not revealed this phenomena as the first presentation of Waldenstr6m's macroglobulinaemia in an emergency department. M HARBORD*, S IVANOVA, N AKHTAR*, Y GUPTA, *Department ofMedicine and Haematology and Department ofAccident and Emergency, King George Hospital, Barley Lane, Goodmayes, Essex IG3 8YB. Correspondence to: Mr Gupta, Consultant in Accident and Emergency. 
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